US Stocks
ITeos Therapeutics Inc
ITeos Therapeutics Inc

ITeos Therapeutics Inc (ITOS)


  • $







Key Stats

Today Low/High$36.04 / $37.7
52 Week Low/High$17.43 / $52.43
Market Cap$1.4B

Company Details

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of cancer immunology and immunosuppressive pathways to design novel product candidates with the potential to fully restore the immune response against cancer. The Company’s innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes. The initial antibody product candidate, EOS-448, is a high affinity, potent, anti-TIGIT antibody with a functional Fc domain, designed to enhance the anti-tumor response through a multifaceted immune modulatory mechanism. An open-label Phase 1/2a clinical trial of EOS-448 is ongoing in adult cancer patients with advanced solid tumors with preliminary data indicating clinical activity as a monotherapy and a favorable tolerability profile. The Company is also advancing inupadenant, a next-generation adenosine A2A receptor antagonist tailored to overcome cancer immunosuppression. iTeos is conducting an open-label multi-arm Phase 1/2a clinical trial of inupadenant in adult cancer patients with advanced solid tumors. Preliminary results indicate encouraging single-agent activity in the dose escalation portion of the trial. iTeos Therapeutics is headquartered in Cambridge, MA with a research center in Gosselies, Belgium.
OrganisationITeos Therapeutics Inc
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is ITeos Therapeutics Inc (ITOS) share price today?

Can Indians buy ITeos Therapeutics Inc (ITOS) shares?

How can I buy ITeos Therapeutics Inc (ITOS) shares from India?

Can Fractional shares of ITeos Therapeutics Inc (ITOS) be purchased?

What are the documents required to start investing in ITeos Therapeutics Inc (ITOS) stocks?